Instrument Inactif

Communiqués Vitro Diagnostics, Inc.

Actions

05/10/20	VITRO DIAGNOSTICS INC : Regulation FD Disclosure (form 8-K)	AQ
05/10/20	VITRO DIAGNOSTICS INC : Other Events (form 8-K)	AQ
14/07/20	Vitro Diagnostics : Biopharma 2nd Quarter ended April 30th 2020 Financial Results of Operations	AQ
09/07/20	VITRO DIAGNOSTICS INC : Regulation FD Disclosure (form 8-K)	AQ
04/06/20	VITRO DIAGNOSTICS INC : Entry into a Material Definitive Agreement, Regulation FD Disclosure (form 8-K)	AQ
27/03/20	Vitro Diagnostics : Biopharma First Quarter 2020 Financial Results of Operations	AQ
04/02/20	VITRO DIAGNOSTICS : Regulation FD Disclosure (form 8-K/A)	AQ
27/01/20	VITRO DIAGNOSTICS INC : Regulation FD Disclosure (form 8-K)	AQ
23/01/20	Vitro Diagnostics : Leading Denver-Based Orthopedic Surgeon to Join Vitro Biopharma's Scientific Advisory Board	AQ
14/12/10	VITRO DIAGNOSTICS : New Results Reveal Extensive Competitive Advantages of VitroGrow? Stem Cell Culture Media	BU
19/10/10	VITRO DIAGNOSTICS : Vitro Expands HemoGenix Alliance to Include Cell-based Testing for Liver Toxicity	BU
27/07/10	VITRO DIAGNOSTICS : Vitro Enters Contract to Develop Stem Cell-Derived Food	BU
15/06/10	VITRO DIAGNOSTICS : Vitro and HemoGenix® Launch New Products at an International Stem Cell Meeting	BU
20/05/10	VITRO DIAGNOSTICS : Vitro CEO Interviews with Wall Street Reporter Regarding New Stem Cell Tools for Cellular Medicine	BU